JP2022518479A5 - - Google Patents

Info

Publication number
JP2022518479A5
JP2022518479A5 JP2021542150A JP2021542150A JP2022518479A5 JP 2022518479 A5 JP2022518479 A5 JP 2022518479A5 JP 2021542150 A JP2021542150 A JP 2021542150A JP 2021542150 A JP2021542150 A JP 2021542150A JP 2022518479 A5 JP2022518479 A5 JP 2022518479A5
Authority
JP
Japan
Prior art keywords
hdl
spherical
core
dna
spherical hdl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021542150A
Other languages
English (en)
Japanese (ja)
Other versions
JP7546927B2 (ja
JP2022518479A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/015109 external-priority patent/WO2020154705A1/en
Publication of JP2022518479A publication Critical patent/JP2022518479A/ja
Publication of JP2022518479A5 publication Critical patent/JP2022518479A5/ja
Application granted granted Critical
Publication of JP7546927B2 publication Critical patent/JP7546927B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542150A 2019-01-24 2020-01-24 脂質結合体化コア足場を使用する高密度リポタンパク質模倣ナノ粒子 Active JP7546927B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962796534P 2019-01-24 2019-01-24
US62/796,534 2019-01-24
PCT/US2020/015109 WO2020154705A1 (en) 2019-01-24 2020-01-24 High-density lipoprotein mimetic nanoparticles using lipid conjugated core scaffolds

Publications (3)

Publication Number Publication Date
JP2022518479A JP2022518479A (ja) 2022-03-15
JP2022518479A5 true JP2022518479A5 (cg-RX-API-DMAC7.html) 2024-05-08
JP7546927B2 JP7546927B2 (ja) 2024-09-09

Family

ID=71736549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021542150A Active JP7546927B2 (ja) 2019-01-24 2020-01-24 脂質結合体化コア足場を使用する高密度リポタンパク質模倣ナノ粒子

Country Status (9)

Country Link
US (1) US12502354B2 (cg-RX-API-DMAC7.html)
EP (1) EP3914236A4 (cg-RX-API-DMAC7.html)
JP (1) JP7546927B2 (cg-RX-API-DMAC7.html)
CN (1) CN113613635A (cg-RX-API-DMAC7.html)
AU (2) AU2020210881A1 (cg-RX-API-DMAC7.html)
CA (1) CA3127256A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021008940A (cg-RX-API-DMAC7.html)
SG (1) SG11202107156WA (cg-RX-API-DMAC7.html)
WO (1) WO2020154705A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2525780B1 (en) 2010-01-19 2022-09-07 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
US20230173096A1 (en) * 2020-05-18 2023-06-08 Northwestern University Targeted antiviral drugs
AU2021364385A1 (en) * 2020-10-23 2023-06-01 City Of Hope Hydrophobic drugs in organic core high density lipoprotein (hdl) nanoparticles
KR102402620B1 (ko) * 2021-06-01 2022-05-30 임덕수 약물 전달을 위한 고밀도 지단백 모방 고형 지질 나노입자 및 이의 용도
WO2025043049A2 (en) * 2023-08-22 2025-02-27 Northwestern University Lipoprotein-like nanoparticles with an organic core and use thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677272B1 (fr) * 1991-06-05 1995-03-03 Biovecteurs As Vecteur particulaire a tropisme selectif, procede de preparation et composition pharmaceutique.
US6361944B1 (en) 1996-07-29 2002-03-26 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6506564B1 (en) 1996-07-29 2003-01-14 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
AU2008212820B2 (en) 2007-02-09 2014-01-30 Northwestern University Particles for detecting intracellular targets
CA2679586A1 (en) 2007-02-27 2008-10-23 Northwestern University Molecule attachment to nanoparticles
EP2826863B1 (en) 2007-05-30 2017-08-23 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
JP5539962B2 (ja) 2008-04-25 2014-07-02 ノースウェスタン、ユニバーシティ コレステロールを隔離するのに適したナノ構造体
US20120277283A1 (en) 2009-08-04 2012-11-01 Mirkin Chad A Localized Delivery of Gold Nanoparticles for Therapeutic and Diagnostic Applications
WO2011028847A1 (en) 2009-09-01 2011-03-10 Northwestern University Polyvalent polynucleotide nanoparticle conjugates as delivery vehicles for a chemotherapeutic agent
US20110111974A1 (en) 2009-10-23 2011-05-12 Northwestern University Short Duplex Probes for Enhanced Target Hybridization
CN102666879B (zh) 2009-10-30 2016-02-24 西北大学 模板化的纳米缀合物
US20130178610A1 (en) 2009-12-24 2013-07-11 Chad A. Mirkin Oligonucleotide specific uptake of nanoconjugates
EP2525780B1 (en) 2010-01-19 2022-09-07 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
US20140134658A1 (en) 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
US9901616B2 (en) 2011-08-31 2018-02-27 University Of Georgia Research Foundation, Inc. Apoptosis-targeting nanoparticles
EP2817024B1 (en) 2012-02-22 2019-07-10 Northwestern University Nanostructures for treating cancers
US10568898B2 (en) 2013-08-13 2020-02-25 Northwestern University Lipophilic nanoparticles for drug delivery
WO2015168393A1 (en) 2014-04-30 2015-11-05 Northwestern University Nanostructures for modulating intercellular communication and uses thereof
US10413565B2 (en) 2014-04-30 2019-09-17 Northwestern University Nanostructures for modulating intercellular communication and uses thereof
DE102014112088A1 (de) * 2014-08-25 2016-02-25 Karlsruher Institut für Technologie Verfahren zur Herstellung mikroporöser organischer Membranen, mikroporöse organische Membranen und deren Verwendung
US10517924B2 (en) 2014-11-24 2019-12-31 Northwestern University High density lipoprotein nanoparticles for inflammation
EP3236955A1 (en) * 2014-12-22 2017-11-01 University of Georgia Research Foundation Inc. Nanoparticles for lipid homeostasis
US10078092B2 (en) 2015-03-18 2018-09-18 Northwestern University Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
EP3298140B1 (en) 2015-05-19 2024-04-24 Yale University Compositions for treating pathological calcification conditions, and methods using same
EP3389635A4 (en) 2015-12-18 2019-08-07 Northwestern University STAIN OXIDE-RELATED NANOPARTICLES OF SIMILARITY WITH HIGH-DENSITY LIPOPROTEINS
EP3426316B1 (en) 2016-03-08 2023-10-25 Northwestern University Delivery of nitric oxide-releasing phospholipids, liposomes, and high density lipoprotein-like nanoparticles (hdl nps) by drug eluting stents and intra-arterial injection
US10967072B2 (en) 2016-04-27 2021-04-06 Northwestern University Short interfering RNA templated lipoprotein particles (siRNA-TLP)
AU2017328956A1 (en) 2016-09-15 2019-04-04 Northwestern University Nanoparticles as catalytic substrates for real-time biosensing of human performance and diagnostic and therapeutic methods
US20210332404A1 (en) 2017-06-21 2021-10-28 Northwestern University Lipid nanoparticles for measuring chronic and acute response to exercise
SG11202111066UA (en) 2019-04-26 2021-11-29 Univ Northwestern High density lipoprotein nanoparticles and rna templated lipoprotein particles for ocular therapy
WO2020231860A1 (en) 2019-05-10 2020-11-19 Northwestern University Orally delivered lipid nanoparticles target and reveal gut cd36 as a master regulator of systemic lipid homeostasis with differential gender responses
US20220331445A1 (en) 2019-09-18 2022-10-20 Northwestern University High density lipoprotein-like nanoparticles as inducers of ferroptosis in cancer
US20230173096A1 (en) 2020-05-18 2023-06-08 Northwestern University Targeted antiviral drugs
US12599677B2 (en) 2020-10-05 2026-04-14 Northwestern University Targeted PH sensitive liposomes
AU2021364385A1 (en) 2020-10-23 2023-06-01 City Of Hope Hydrophobic drugs in organic core high density lipoprotein (hdl) nanoparticles

Similar Documents

Publication Publication Date Title
Hu et al. Physiological barriers and strategies of lipid‐based nanoparticles for nucleic acid drug delivery
US20240016737A1 (en) Synthetic Nanostructures Including Nucleic Acids and/or Other Entities
JP7600208B2 (ja) 拘束された脂質を含むナノ材料およびその使用
Allain et al. Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices
CN101903018B (zh) 用于递送核酸基因的ldl样阳离子纳米微粒、其制备方法以及使用其递送核酸基因的方法
JP4291412B2 (ja) リポソーマルホスホジエステル、ホスホロチオエート、およびp−エトキシオリゴヌクレオチド
US20100166842A1 (en) Amphiphilic substances and functionalized lipid vesicles including the same
US20080242625A1 (en) Nucleotide-Cochleate Compositions And Methods Of Use
JP2011503070A (ja) 全身遺伝子送達のための自己構築型ミセル様ナノ粒子
CN101932310B (zh) 制备基于官能两亲分子或者大分子的纳米颗粒的方法和其用途
WO2012124688A1 (ja) 肺送達のためのベクター、導入剤及び使用
Zhang et al. Construction of a targeting nanoparticle of 3′, 3 ″-bis-peptide-siRNA conjugate/mixed lipid with postinserted DSPE-PEG2000-cRGD
Zhou et al. Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids
Le Gall et al. Effects of a novel archaeal tetraether-based colipid on the in vivo gene transfer activity of two cationic amphiphiles
Rouquette et al. Adenosine and lipids: A forced marriage or a love match?
CN107951861A (zh) 一种脂质纳米粒膜材料组合物
CN101541307A (zh) 自发形成的椭圆体磷脂单层囊泡
JP3910646B2 (ja) 「細胞への遺伝子導入用組成物」
US20120178793A1 (en) Nucleotide-cochleate compositions and methods of use
Pili et al. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation
EP1007097B1 (fr) Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
WO2023245175A2 (en) Targeted nanomedicine for treating arterial disease
EP3662934A1 (en) Composition for gene therapy of the central nervous system, process of production and use thereof
Aranda-Lara et al. Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview
Antimisiaris Liposomes in drug delivery: what, where, how and when to deliver